

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on improving the lives of children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. The company's novel und...
Q2 2026
Aug 6, 2026
Q1 2026
May 7, 2026
FY 2025
Mar 3, 2026
Q4 2025
Mar 3, 2026
Q3 2025
Nov 14, 2025